GPX2 and gastric adenocarcinoma: To further confirm GPX2 expression in DGC, we analyzed its levels in the gastric adenocarcinoma (STAD) cohort from The Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG), and the results revealed heightened increased GPX2 expression in GC (Fig. 2A, B).